This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
"Billions served" wasn't about the number of unique customers. By the time they stopped posting the counter in the 90s, they were up to 100 billion. It was the number of orders served.
Even so, I think they didn't get to that number by skimming for the obsessives.
More options
Context Copy link
More options
Context Copy link